About
Hayhurst Medical Technologies is a medical device development company based in Kansas City, Missouri, focused on intraoperative innovations for surgical oncology. The company is currently developing a novel device for closed-technique hyperthermic intraperitoneal chemotherapy (HIPEC) perfusion, with provisional patent on file.
Building engineering and ecosystem relationships in Kansas City and the regional medtech corridor. Preparing for NIH SBIR Phase I submission.
Founder
Joseph L. Hayhurst, MD — physician-founder with prior training in general surgery. Also founder of HippocrAI, an open-source library of AI agents for medical device development.